Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature

Published:2007-05-26 Issue:2 Volume:85 Page:229-230
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Singhal Nimit,Selva-Nayagam Sudarshan,Brown Michael P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-007-9403-6.pdf

Reference8 articles.

1. Stupp R, Mason WP, van den Bent MJ et al (2005) radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

2. Spence AM, Kiem HP, Partap S, Schuetze S, Silber JR, Peterson RA (2006) Complications of a temozolomide overdose: a case report. J Neuro-Oncol 80:57–61

3. Hartmann P, Herholz K, Salzberger B, Petereit HF (2004) Unusual and severe symptomatic impairment of neutrophil function after one cycle of temozolomide in patients with malignant gliomas. Ann Hematol 83:212–217

4. Su YW, Chang MC, Chiang MF, Hsieh RK (2005) Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma. J Neuro-Oncol 71(3):315–318

5. Noronha V, Berliner N, Ballen KK, Lacy J, Kracher J, Baehring J, Henson JW (2006) Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature. Neuro-oncol 8(3):280–283

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive understanding of the adverse effects associated with temozolomide: a disproportionate analysis based on the FAERS database;Frontiers in Pharmacology;2024-08-23

2. Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors;Journal of Neuro-Oncology;2024-02-16

3. Use of surface-modified porous silicon nanoparticles to deliver temozolomide with enhanced pharmacokinetic and therapeutic efficacy for intracranial glioblastoma in mice;Journal of Materials Chemistry B;2024

4. Temozolomide and flavonoids against glioma: from absorption and metabolism to exosomal delivery;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-08-11

5. Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma;Journal of Controlled Release;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3